SEC Form 4 · accession 0001179110-17-003717
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart A Kingsley
Officer — President and COO
Period of report
Mar 1, 2017
Accepted (ET)
Mar 2, 2017 · 7:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2017 | A | 11,386 | $0.00 | A | 11,386 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right-to-buy)F2 | $52.70 | Mar 1, 2017 | A | 70,265 | A | — | Mar 1, 2027 | Common Stock | 70,265 | 70,265 | D |
Explanation of responses
- F1Shares of restricted stock vest in 25% increments on each anniversary of the date of grant, until fully vested.
- F2The option vests in forty-eight equal installments beginning April 1, 2017.